Rockwell Medical Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ROCKWELL MEDICAL INC, and what generic alternatives to ROCKWELL MEDICAL INC drugs are available?
ROCKWELL MEDICAL INC has three approved drugs.
There are two US patents protecting ROCKWELL MEDICAL INC drugs.
There are nine patent family members on ROCKWELL MEDICAL INC drugs in eleven countries.
Summary for Rockwell Medical Inc
| International Patents: | 9 |
| US Patents: | 2 |
| Tradenames: | 2 |
| Ingredients: | 1 |
| NDAs: | 3 |
Drugs and US Patents for Rockwell Medical Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rockwell Medical Inc | TRIFERIC | ferric pyrophosphate citrate | SOLUTION;INTRAVENOUS | 206317-002 | Sep 4, 2015 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Rockwell Medical Inc | TRIFERIC AVNU | ferric pyrophosphate citrate | SOLUTION;INTRAVENOUS | 212860-001 | Mar 27, 2020 | DISCN | Yes | No | 7,816,404 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Rockwell Medical Inc | TRIFERIC | ferric pyrophosphate citrate | POWDER;INTRAVENOUS | 208551-001 | Apr 25, 2016 | DISCN | Yes | No | 7,816,404 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Rockwell Medical Inc | TRIFERIC | ferric pyrophosphate citrate | SOLUTION;INTRAVENOUS | 206317-001 | Jan 23, 2015 | DISCN | Yes | No | 7,816,404 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Rockwell Medical Inc | TRIFERIC | ferric pyrophosphate citrate | POWDER;INTRAVENOUS | 208551-001 | Apr 25, 2016 | DISCN | Yes | No | 7,857,977 | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Rockwell Medical Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Rockwell Medical Inc | TRIFERIC | ferric pyrophosphate citrate | SOLUTION;INTRAVENOUS | 206317-001 | Jan 23, 2015 | 6,689,275 | ⤷ Subscribe |
| Rockwell Medical Inc | TRIFERIC | ferric pyrophosphate citrate | SOLUTION;INTRAVENOUS | 206317-001 | Jan 23, 2015 | 6,779,468 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Rockwell Medical Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2550493 | ⤷ Subscribe |
| Slovenia | 2016940 | ⤷ Subscribe |
| Cyprus | 1113903 | ⤷ Subscribe |
| Portugal | 2016940 | ⤷ Subscribe |
| Denmark | 2016940 | ⤷ Subscribe |
| Austria | E554754 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
